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i 
The empty interior cavity of hllerenes has long been touted for containment of radionuclides during in 
vivo transport, during radioimmunotherapy (RIT) and radioimaging fbr example. As the chemistry 
required to open a hole in fullerene is complex and exceedingly unlikely to OCCUT in vivo, and the 
conformational stability of the Mlerene cage is absolute, atoms trapped within Merenes can only be 
released during extremely energetic events. Encapsulating radionuclides in lllerenes could therefore 
potentially eliminate undesired toxicity resulfing from leakage and catabolism of radionuclides 
administered with other techniques. A the start of this project however, methods for production of 
transition metal and p-clectron metaI endohedral lllerenes were completely unknown, and only one 
method for production of endohedral radiolllerencs was known. We thedore investigated three 
different methods for the production of therapeutically useful endohedral metallohllerenes: 1) 
implantation of ions using the high intensity ion beam at the Oak Ridge National Laboratory (ORNL) 
Surface Modification and C- * 'on Research Center (SMAC) and fullereaes as the targe 2) 
Implantation of ions using the recoil energy following alpha decay; and 3) implantation of ions using the 
recoil energy Mowing neutron capture, using O W ' S  High Flux Isotope Reactor (HFIR) as a thermal 
neutron source. While we were unable to obtain evidence of successful implantation using the ion beam at SMAC, recoil following alpha decay and neutron capture were both found to be economically viable 
methods for the production of theqmtically usefid radiofidlerenes. In this report, the procdms for 
Preparing fullerenes containing the isatopes '"Pb, "'Bit "%i, and lnLu are described. None of these 
endohedd fullerenes had ever previously been pmpamd, and all of these radioisotope8 are actively under 
investigation for RIT. Additionally, the chemistry for derivatizing the radiofullerens for water-solubility 
and a method for removing exohedral radionuclides are reported. The methods and chemistry developed 
during this CRADA the crucial first steps for the development of Ml-es as a method superior to 
existing technologies for in vivo transport of radionuclides. 
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1. Introduction 
Fullemes, also known as “buckyballs,” are carbon clusters which have cagelike stn~ctms. Their 
geodesic structures, resembling soccer balls, are formed by the sequential bonding of cyclic carbon 
structures. Soon after their discovery in 1985 (Kmto et al., 1985), it was recognized that a small molecule 
or atom could be trapped inside the empty cage (FiireFigwe 1; Heath et al., 1985). Indeed, when the 
Mlerenes are formed in the presence of certain metal ions, particularly the lanthanides, the metal atom is 
often trapped within the Illenme cage. For example, Y@C, means a yttrium atom is trapped within the 
Although M e  represents the largest 
component of so-called “endohedral” lllerenes produced by 
typical methods, in general only M@Ca and a few select other 
larger lllerenes survive the puritication process by solvent 
extraction (Diener and Alford, 1998). 
Endohedral metallolllerenes have been prepam3 h m  
electropositive metals like alkaline earth metals (Group 2, save 
magnesium) and lanthanides and uranium (Group 3). The 
standard technique is co-vaporization of carbon and the metal by 
arc discharge or laser ablation (Chai et al., 1991). So far, attempts 
to produce lllerenes containing transition metals by these 
techniques have not been successfbl. Noble gas endohedral 
lllerenes have also been prepared with very low yields by high 
pressure, high temperahre techniques that essentidly squeeze a Figure 1. C, containing an 
few gas atoms into the lllerene cage (Saunders et al., 1994). encapsulated atom. 
Techniques based on recoil Erom gamma- ray emission following 
neutron capture have also been usxi to generate a range of endohedral hllerenes, including lllerenes 
containing Sb, As, and Se, but again the yield is very low (Ohtsulci et al., 2000). Light ions - specifically 
He” and Li’ - have been ion implanted in Werenes at respectable yields (Gromov et id., 2003). 
lllerene cage. 
1 
It is now g e n d l y  acceptd that due to exceptional cage stability with respect to cage opening, combined 
with the ease at which the outer surfaces can be functionalized, endohedral lllerenes show great promise 
in a number of areas of medical diagnosis and treatment. It is envisioned that metallolllerenes could 
provide an alternative to chelating compounds currently used in nuclear medicine because of their 
resistance to metabolism, as well as their high thermodynamic and kinetic stability. Our recent work has 
shown that radiolllerenes can be successfully isolated, derivatized and solubilized. By irradiating pre- 
purified 16%o@C, in the ORNL High Flux Isotope Reactor (HFIR), ‘%@a was produced. 
Holmium-166, a beta-emitting radioisatope with a half-life of 624 is of interest for therapeutic 
applications in nuclear medicine. The results of this pioneer study, a collaboration between ORNL, TDA 
Research, and Rice University, were published in the F%wxedm * gs of the National Academy of Sciences 
(v. 96, p. 5182). 
This project began as an investigation of the high intensity ion beams available at O W ’ S  Surface 
Modification and C h m  ’ ‘on (SMAC) Research Center. Since SMAC is capable of producing a 
number of lransition m d  ions, the project was expected to lead to the discovery of new endohedral 
Illenmes. The most important metal to be encapsulated was believed to be Copper. However, results 
h m  experiments there were discouraging, and shortly after SMAC was permanently shut down for lack 
offimding. 
The project was then amended to refmus on pmduction of radiofdlerenes by recoil. During recoil 
implantation, the radionuclides encapsulated into the lllerene are carrier fiee, i.e., the activated metal is 
2. 
3. 
isolated h m  the non-activated metal by the fullerene, thus producing radiofullerenes with very high 
specific activities (a new variation of the well known Szilard-Chalmers effed). The chemical differences 
between the radionuclide and the metallofullerene provide a basis for rapid sepmtion of encapsulated 
h m  u n e n q u l d  radionuclides. The recoil implantation can also produce radiofidlerenes from 
elements that cannot be incaporated into fullerenes by carbon vapor synthesiis. 
In the second series of experiments, various therapeutically useful alp- . ' g radionuclides were 
encapsulated by recoil following alpha-decay of a parent radionuclide. This work prepared for the fvst 
time endohedral lead (Pb) and bismuth (Bi) fullerenes, specifically the '"Pb, 'I2Bi, and ''%i 
radioisotopes, all of which are of great interest for state-of-the-art cancer therapies. Indeed, the use of 
recoil h m  alphadecay to firm endohedral fullerenes have never previously been demonstrated, and, 
given the high kinetic energies of the m i l i n g  nuclei, there was ample mason to question whedher it 
would work or not. Techniques for the rapid elimination of exohedral radioisaQpes and d e r h h t ~  'on for 
water solubility wem also developed. Finally, a yliminary biodistriubtion study showed that, as 
expected, encapsulation in the Merene prevented 'Pb from locating in the bones of mice, as it does 
when lost h m  chelators in vivo. 
In a third series of experiments, lnLu endohedral fullerenes were produced by neutron activation. While 
at first blush, this may seem to be an obvious extension of existing work, it was fhmd that much of the 
existing work on neutron activation greatly overestimated the success ofthe technique. is also of 
tremendous interest in the current development of advanced can- therapies. Since only activated Lu is 
trapped in the fullerene, the d i f f i  between fullerene chemistry and Lu chemistry provides for an 
essentially instant Sepatation of activated Lu from cold Lu, thereby providing der - fke  lnLu, which is 
otherwise obtainable only by tedious and expensive a d i t i d  process step. separation of malonic esters 
of '77L@Cm from empty Ca by rapid Hpu: was also developed. 
This final report for the TDA-ORNL CRADA documents all three series of experiments in the order in 
which they were performed and described in the introduction While the original plan to produce 
transition metal endohedral fullerenes did not proceed successfully, a tremendous amount of exciting 
discoveries were made with other techniques that can essentially only be pract id at ORNL's unique 
radiological facilities. 
Ion Implantation at SMAC 
The first part of this project used the high intensity ion beam at ORNL's Sh4AC as a source of transition 
metal ions accelerated to sufficiently hi& energies to be implanted into c60. Although various beam 
cutrents and copper ion energies were tested, no evidence could be found for C U @ & O  by laserdesorption 
time-of-flight mass spectrometry (LD-TOF-MS). The detection limit for the TOF-MS b e n t  at that 
time was approximately one part in one thousand for easily ionizable copper endohedd Illerenes. It is 
possible that the technique was successfd at lower yields, but such low yields are not of commercial 
interest. Following this series of experiments, we moved on to utilize other unique facilities at ORNL for 
the production of marketable, therapeutictlrly usem e n d o w  fidlerenes. 
Implantation by Recoil Following AlpBrr-partide Deery 
The second part of this project sought to recoil the nucleus following alpha-particle decay into the cavity 
of Ca. The daughter nucleus breaks through a few fullercnes, losing energy, until some nuclei run out of 
kinetic energy while they are inside of a fullerene. Since fullemnes are extremely inexpensive in 
comparison to alpha-emithg radionuclides, and the value of therapeutically useM radiohllerenes is 
expected to be quite high, a low conversion of fdlerenes to endohedral fullerenes is irrelevant. However, 
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the radionuclide to be encapsulated must be chosen very careMy, so as to maximize the ultimate 
economic value of radiofullerene. 
The best use of radiolllerenes is thought to be in radioimmunotherapy (RIP Milenic et al., 2004, e.g.). 
In RIT, metallic radionuclides are contained in polyaminocarboxylate (PAC) chelators, wherein three or 
more secondary amines and carboxylic acids chelate the radionuclide, largely sheltering it from the 
external environment. The chelated radionuclides are them delivered to cancer cells by chemically 
attaching the radionuclide to an antibody, antibody hgment, or peptide that is specific for receptors 
expressed solely (or at least preferentially) on the cancer cells. Following arrival of the radionuclide - 
antibody conjugates at the cancer cell, decay products from the radionuclides can then break strands of 
the cell's DNA, thereby killing the cancerous cell. RIT using PAC chelators and beta-emitting 
radionuclides has recently become an attractive method for the treatment of B-cell non-Hodgkin's 
lymphoma (NHL), with two radiophamaceuticals approved by the FDA. 
Effective targeting of the radionuclides remains the primary challenge in RIT (Sharkey et al., 2004, e.g.). 
Current limitations in targeting efficacy restricts effective use of RIT to attack on cancerous cells that 
have tremendous exposure to circulating blood (and thus the circulating antibody conjugate). The 
haematological malignancies that can be effectively targeted frequently have a significant portion (if not a 
majority) of the cancerous cell volume consisting of single cells or aggregates of a few cells, tens of 
microns in diameter, much smaller than the distance over which fbparticles distribute their energy in vivo 
(millimeters). Therefore, p-decays in RIT invariably primarily damage healthy tissues. Moreover, a single 
beta decay is insufficient to break more than one strand of DNA, and single-strand breaks can be readily 
repaid. M i c r o d o s i i  calculations indicate that hundreds of thousands of beth-pmticles are requined to 
have a 99.99% chance of killing a cell. Conv-ly, only hundreds of alpha-particles are required for the 
same probability of killing the cell, and the m g e  of alpha decays in vivo is -50 mimns. Although the 
FDA-approved NHL therapies use one of two beta-emitting radionuclides fl or "'I), it is widely agreed 
that alpha particles therefbre have ideal . 'cs forthe treatment ofthe cancers that RIT can most 
effectively target. Fu~themore, complexes of lanthanide radionuclides with existing PAC chelators 
appear to be sufficiently stable for use in current RIT applications, obviating the need for Mlerenes. 
Despite the favorable properties of a-particle radiation, development of a-particle RIT has been limited 
by the poor availability andor physical characteristics of a-emitting radionuclides. These intrinsic 
drawbacks have limited development of a-emitters, while focusing attention on &emmiten. (One 
potential use of hllerenes in beta-particle RIT is given in Section 4.) Several reviews have debated the 
relative strengths and weaknesses of the available a-emitting radionuclides (Couturier et al., 2005; 
Mulford et al., 2004; Zalutsky and Pozzi, 2004; Mirzadeh, 1998). Currently, most effort is focused on 
211At, 225Ac and 21%i. The decay characteristics of "'At are very attntctive (single decay to ground state, 
tln =7.2h), but, usin current state-of-the+ut production methods (Zalutsky et al., 2001), the creation of 
one human'dose of At requires about one day of operation at an unusually large cyclotron, and is 
therefore most likely to be prohibitively expensive for the foreseeable future. *Ac (ttn = 10 days) is 
readily available h m  stockpiled 23%J, and generator systems have been developed for its daughter 213Bi 
(tin = 45 min). While both of these radionuclides can be satisfactorily chelated by a PAC, the four a- 
emitting daughters of "5A~ (Figure 2) are not retained in the PAC and ate free to redistribute. A recent 
primate study demonstrated dose-limiting renal toxicity, believed to result fiom free '13Bi decays 
(Miederer et al., 2004). So far, none of the approaches to c o d  the daughters have been successful (Jaggi 
et al., 2005), and given the high recoil energy of a-decays, it is also very unlikely that lllerenes could be 
of assistance. While *13Bi decays directly to a stable isotope, its short half life requires more efficient 
targeting than is currently available (Adams et al., 2000). 
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Figure 2: The major decay pathways for generating therapeutically useful a-emitting radionnuclides 
The original RIT studies were performed with a fourth isotope, 212Bi, in l a r g e p  because both parent 
material and a generator system were readily available. The decay chain of Th, of which 212Bi s a 
daughter, is shown in Figure 2. The half life 212Bi creates the same limitations as for 21%i, but that 
problem can potentially be overcome by using 212Pb. While 212Pb is a beta emitter, it is desirable for a- 
particle RIT because its 10.6 h half-life increases by tenfold the time available to get 212Bi to the target 
tissue before a-decay. However, while DOTA and other chelators can apparently chelate 212Pb 
satisfactorily in saline solutions (Mirzadeh et al., 1993; Chappel1 et al., 2000, Chon et al., 2006), in vivo 
tests resulted in severe myelotoxicity, presumably the result of bonetargeting 212Pb lost or transchelated 
out h m  the DOTA (Ruble et al., 1996, Horak et al., 1997; Chong et al., 2006). Furthermore, the internal 
conversion following 36% of the beta decays to 212Bi also released the daughter from the DOTA. The use 
of a fullerene instead of a chelator could potentially solve both problems with 212Pb, thereby making the 
2'2Pb/2'2Bi system attradive for RIT. If the lllerene was sUCCeSSfUl the only significant remaining 
drawback to its use is the h u ~  gamma-ray emitted by the daughter. Yet, compared to the 
outstanding problems with Ac and '%i, solutions for shielding health care personnel h m  high-energy 
gamma-rays are well known, and inexpensive compared to the costs of '''At production. 
R 
Herein is reported the synthesis of 212Pb@C~ by recoil following udecay of its short-lived parent 
(Section 3.1), the formation of water-soluble 212Pb@Ca malonic acids (Section 3.2.1), the stability of the 
radiolllerene during beta&y (Section 3.2.2), and a preliminary biodistribution study of the untargeted 
water-soluble radiofullerene in mice (Section 3.3). To our knowledge, this is the first endohedral fullerene 
formed by recoil from a-decay, the first endohedral lead fbllerene, the fmt fillerene encapsulating an a- 
emitting radionuclide with a therapeutically useful half-life, and the first biodistribution study of hllerene 
malonic acids. S i  we began this work, two reports of new chelators for 2'2Pb have appeared, but the 
results appear to indicate that further development or a new approach (i.e., fullerenes) is required. 
4 
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3.1 Implantation by Recoil Following Alpba Decay 
3.1.1 Radioactivity Measurements 
Since a-particles do not penetrate very far into a dense medium, it is more common to assess the presence 
of the a-emitling radionuclide by measuring the number of gamma ray(s) emitted as part of the a-decay 
processes. The gamma rays are measured by a cooled germanium detector The instrument had previously 
been calibrated for detector efficiency as a function of both the photon en- and distance between the 
sample and the detector. The calibration factor was then multiplied by the probability of the photon being 
emitting during the decay, as given in a table of the isotopes. The resolution of the instrument as operated 
was 0.5 keV. Gamma rays were typically observed between 10 and lo00 keV. A software program then 
calculated the area under the peaks corresponding to emitted photons. The peak areas were then converted 
to the activity of each component of the sample using the calibration factor and photon probability 
product. 
Since the probability of a certain photon being emitted varies widely accodng to the photon, it can be 
advantageous to track the presence of certain isotopes through their daughtem. For example, ='Ac emits 
no photons with a probability much greater than 1%, while the 217 keV and 440 keV photons fkom '"Fr 
and 213Bi are emitted 12 and 26% of the time, respective1 . Thus, the short-lived y t e r s  of 2zAc, ='Fr 
andor 213Bi are typically used to track the presence of Ac m this study. Similarly, 12Bi can be tracked 
much more effectively via the 583 keV photon emitted 86% of the time (using the appropriate 
correction factor), than with its own weak 727 eV gamma ray. mRa can be tracked via its 241 keV 
photon. Generally, collecting data for five minutes at the appropriate distance to the detector was 
sufficient to assess the radionuclide content of the sample down to sub-nanocurie levels. 
J 
3.1.2 Early Work; Ion Implantation When this project was stark4 only three methods were 
known for encapsulating atoms in fullerenes: 1) During the formation of the fullerene by condensation of 
carbon (and metal) vapor (Chai et al., 1991); 2) Under high pressures and temperatures of the atom to be 
encapsulated (Saunders et al., 19%); 3) During recoil following thermal neutron capture (Rawch and 
Braun, 2001). Since therapeutic a-emitting radionuclides are, generally speaking, not produced by 
neutron activation, the third method was not relevant- High pressure methods are typically useful only for 
gases, such as helium, and the yields are very low. 
However, ORNL team found a simpler, cleaner method while this proposal was under =view. In this 
method, =Ac was He electroplated onto one disk, coated a secund disk with Cao, applied a a potential of 
a few kV between the two disks (electsodes), and within a few hours "%i@C, was found on the CW 
disk. During a-decay of ='Ac, the Francium daughter possesses significant kinetic energy, and for a very 
short period of time s) it is very highly charged. In the presence of the electric field, the '"Fr ions 
are accelerated across the gap and, absent of any obstacle, are implanted either in the lllerene lattice, or 
in the fullerenes themselves. If they are in the lattice, the recoil fiom a subsequent decay (of 217At) can 
implant '13Bi in C,. The ORNL team regularly found -20% of the '"Bi expected to have formed during 
the time the disks faced each other on the Ca disk, with 1-2% encapsulated. 
There are significant advantagts of this system over the co-vaporization (arc) method. primarily, the 
parent radionuclide remains sequestered on the disk that does not contain lllerenes and does not require 
handling, allowing it to serve as a generator for future generation of daughm. Also, the equipment is 
simpler, with no moving parts to be operated in a glove box, nor gemmition of high tempera-, nor need 
to confine radioactive dust. 
5 
However, to encapsulate 2zAc in this method requires starting from u9Th, and implanting '%a into the 
Cao as it comes across the gap. (225Ra then p-decays to '=Ac, and the p-decay is not strong enough to 
rupture the hllerene cage.) Typically, atoms require -120 eV before they can be encapsulated in a CM. 
We calculated that a moderate vacuum and a potential of only tens of volts should be sufficient to 
accelerate the 225Ra to at least 120 eV. A 
drawing of the cell used for these experiments ** A - 
is shown in Figure 3. 
Despite meeting these conditions, it was never 
demonstrated that any =Ac was encapsulated 
by this method. One problem was simply 
getting the daughten to cross the gry, between 
the electrodes. When Dr. Minadeh starts from 
during the time which a potential is applied 
between the eledrodes can be found on the 
- M T -  
Rcd-QQc-tIUr 
.b 
t0Y.Drvl .M 
sw m 
m mio Uor T N I m  purified 225Ac, -30% of the 21%i produced MhWaIt 
disk' simi1arly9 more Optimized Figure 3: Cell for implantation of ions following udecay systems can get 60% of the 213Bi dau ter intoMlerenes 
across. We typically found only -1% of '%i 
on the Mlerene disk, and no obvious u5Ac. It is believed that the presence of significant amounts of 
natural thorium 2 3 2 ~  in the 228/229111 mixture resulted in an electroplated film several microns thick, 
preventing the daughters from escaping the surfixe and into the electrostatic field. While we considered 
using the incredibly expensive highly pure 22% (-!§4O/pCi), it also occurred to us that it would be less 
expensive to use mixed material, even if it could not be recycled 
3.13 Coating Radionuclides with hkrenes;  Recoil Implantation 
For example, from 1 mCi of 224Ra, which was extractable from an existing 228R29Th source at ORNL, we 
could generate more than enough for use in mouse biodistribution studies. The %a has no 
materials cost associated with it, as it is usually left to decay while the "'Ac fhm the Th source is 
processed for Sale. nus we incumxi only labor costs for the genedon of a mixed ZuRZsRa material. The 
process was expected to perform as 
1 mci %a =500 pci '%a electroplated 5 pci via recoil implantation 
3 2 - 3 pCi water-soluble 212Pb@C~ derivatives. 
The system we ultimately decided on for producing 2'2Pb@Ca was incredibly simple, even simpler than 
that shown in Figure 3Figure. A mixture of -'Ra was electroplated onto a platinum mesh. A coating 
of Cm was applied by spraying a toluene solution of Cm over the mesh with an artist's airbrush. As the Ra 
atoms and their daughters decay, some adoms are miled into C a  molecules. In the case of wRa, the 
"%I (a noble gas) daughter may assist the process by difftsion and redistributing into the microscopic 
cracks in the Ca coating. Because M@Cm are generally insoluble, we removed the (both C ~ O  
and fiom the mesh by derivatizing them to their malonic ester derivatives, which are then soluble 
in tetrahydrofuran (W), whereas underivatized lllerenees are not. The c h e m i 9  is described in the next 
subsection. Using this method, we were able to obtain 0.1% - 0.5% of the 21 Pb produced during the 
contact time as endohedra~ 2 1 2 ~  derivatives. While not quite as high as hoped for, the coarseness of 
the preparation method can undoubtedly be impmved, and the encapsulation efficiency significantly 
increased. 
Importantly, the Mlerenes could be stripped off without temoving the Ra &om Pt electrode (Table 1). This process is sensitive to the reaction conditions for Ill- esterification, but even during this Phase 
I, only a few percent of the parent radionuclides were removed fhm the source mesh. Many films of 
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fullerenes could therefore be applied and removed from a single radionuclide source. Thus, instead of 
obtaining only -1% of the daughters from the parent in a fullerene, many applications of Cm, and 
subsequent removal by esterification, allows multiple collections (each with -1 % encapsulation 
efficiency). In the example above, 500 pCi of 224Ra could generate tens of pCi of 212Pb@Cm derivatives 
instead of only 5 pCi. 
Table 1 : Activity of select radionuclides remaining on the electroplated Pt meshes after Cm was removed 
by base-catalyzed chemical derivatization (see next section for detail). 
181 41.6 74.1 20.0 39.7 42.5 
Mesh # and Isotope 81: P4Ra #1: 225Ac #2: p4Ra #2: P5Ra #3: p4Ra #3: 225Ra 
Activity at first time point 51.9 226 1 02 119 33.1 43.3 
Activity after fullerene 
removal (much later 
time) 
Expected activity after 45.2 214 58.8 1 04 21.7 39.2 
fullerene removal 
Radionuclide Stability 94% 85% 71% 71 % 92% 101% 
Esterification conditions appear to have been a bit harsher on Mesh #2 than the other 
meshes. 
Most importantly, even when starting from this large mixture of radioisotopes, a combination of hctors 
result in only 212Pb and no other radionuclides being present in the Ca by the time the chemical 
derivatization is finished. Thus, although the ‘kptalce’’ of radionuclides into the Werene is comparatively 
low versus chelators, the uptake process discriminates between radionuclides and obviates the sometimes 
extensive ion chromatography necessary to produce the very pure radioisotopes required by chelators. 
Hi 2’2Pb radiolytic purity is obtained intrinsically by the implantation pracess, even when starting h m  
a 2‘sRa generator. These results are explained further and substantiated in the following subsection. 
3.2 Derivatization and Purification of Ret, 
The process used in this Phase I project started from a Platinum mesh and an aqueous solution of zuMka 
(and their daughters). The radionuclides were electroplated onto the mesh. Then a saturated toluene 
solution of was air brushed onto the radionuclide-coated mesh, and left to stand, typically for 24 - 36 
hours. This section covers the processing to generate water-soluble R@Ca from a fullerene-coated mesh. 
3.2.1 Esteritbtion of Ret,; Wmhimg of the Esters One of the most vefs8tile and basic d o n s  of 
lllerenes is the addition of malonic esters (Figure 4). This d o n  consecutively adds malonic acid 
esters to the fullemne cage. On empty fullerems, the d o n  proweds through addition of the cadmion 
h m  diethylbromomalonate to Cm with -65% yield (Hirsch et ul. 1993). Deprotonation of the a-halo 
ester can be accomplished with NaH or hindered bases such as or 1,8diazobicyclo[5.4.0]undec-7-ene 
(DBU). The current trend in fullerene chemistry has been to use DBU as the base. However, our early 
experiments showed that DBU irreversibly complexed with the metallofillerene rather than deprotonating 
the a-hydrogen of the malonic ester. 
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Figure 4. Malonic ester reaction sequence. 
As discovered in our earlier work (Diener and Alford 1998), the 
metallolllerenes' redox and chemical properties are not quite 
identical to empty fullerenes. Metallolllerenes are much easier to 
reduce than empty fullerenes, explaining their tendency to complex 
with the lone pair of electrons on the DBU. Similarly, the basic 
hydride anion (from NaH) also easily reduces the metallofullerene. 
In this case though, either hydrogen and a reduced metallofullerene 
or a hydrometallofullerene anion is formed. These do not block the 
reaction and both are soluble in the proper solvents such as THF or 
ethyl acetate (EA). The result is a metallolllerene substituted with 
three to ten malonic esters (Bolskar et al., 2001). Additional 
reactions hydrolyze the esters to carboxylic acids, imparting water 
solubility to the metallofullerene (Section 2.2.5). 
The pathway for processing the C ~ O  film into ethyl acetate (EA> 
soluble malonic ester derivatives is shown in Figure 4. The entire 
processing, including the multiple washing steps, can be performed 
in about an hour, although taking time to count every wash increases 
the time to about two hours. Sometimes the THF was transferred to 
the centrifige tube and then centrifuged once, separated h m  the 
solids by transfer to a new tube, and then evaporated, when the ethyl 
acetate is introduced amongst those steps d m  not appear to have any 
effect on the process. The total organic volume was typically about 
one milliliter. T r a n s f h g  was performed with syringes with 
stainless steel needles, typically 27 gauge. The organic solution has a 
characteristic deep reddish-brown color, in contrast to the purple 
color of pure CW. 
C, - Coated, R-plated Pt mesh 
In lOml Twc4kk Flask 
1 
Purge Flask with N, 
Add NaWTHF Slurry 
1 
1 Stirbriefly 
1 ~tir5-10min 
1 
1 
1 
Add Diethylbromomabnate 
Evaporate THF with N, 
Add Ethyl Acetate 
Transfer to Cenbifuge Tube 
Count for ActMty I cmbifw 
Syringe off Supernatant; 
1 
1 "- 
Add Cold PWBiTTVHNOa 
(0.012M) Aqueous Solution 
1 Centrifuge The washing solution was made up with 10 mL of 0.012 M HNO3 
containing 10 @ of 1 .OOO mghL atomic absorption standards of Bi, Pb, and T1. Typically, half a milliliter of the washing solution was 
pipetted into the centrifuge tube contahiing the EA. Vortexhg was 
usually performed for 10 seconds at -2000 rpm. Radioactive metal 
atoms outside of the fullerene exchange and equilibrate with the cold 
metal atoms present in the washing solution. Since there are so many 
more cold metal atoms than radioactive ones, the radioactive atoms 
tend to be washed out. Unless, of course, they are inside of a ~ a r e ~ ~ a s n e c e s ~ ,  
fullerene ester (which is not soluble in water), where they cannot typlcally slx Or seven times- 
exchange with the others. The esters can in principle be dissolved in 
Off upper Organic Layer 
Into Fresh Centrifuge Tube 
1 
count Aqueous; Cwnt Organic 
Figure 4: Processing of the 
fillerene esters. The last three 
8 
toluene, and then washed, but it seems to take longer to wash out the exoheQal radionuclides. Note that 
this procedure will exchange radioactive metal atoms h m  chelators, as well as other more weakly 
chemically bonded systems. 
A typical washing sequence is shown in Figure SError! Reference source not found.. The presence of 
Pb is tracked by the 238 keV y-ray, and ='Ac by the 218 keV y-ray from 4.8-m 221Fr daughter, as 
described on page 6. Data are not time-corrected, but the washings were performed in much less than the 
10.6 hour half life of 212Pb (or the 10 day half life of 225Ac). The radioactive lead atoms outside of the 
fullerene are exchanged and removed in the aqueous portions, while the endohedral "*Pb atoms remain in 
solution. Since beta decay from usRa is not energetic enough to implant *'Ac in a fullerene, all 22'Ac is 
outside of the cage. Figure 5 shows that all of the 4.5 pCi of "'Ac that were on this mesh can be 
separated from those radionuclides that were recoiled into the fullerene with just a few washes. 
212 
.e 
P 
3 4l 
0 I 
I 
L 
I 
3 4 
Wash # 
5 6 7 
Figure 5: Successive washings of 212Pb@Cm malonic ester derivatives in ethyl acetate with dilute nitric 
acid containing cold lead atoms. Removal of atoms not recoiled into the Cm cage is also demonstrated. 
213Bi, however, can be recoiled into Cao, as shown in Figure 6. Because of its short (45.6 min) half lifk, the 
endohedral '13Bi left at the time of the 7* wash was used to back calculate the amount of 213Bi present 
when the Mlerene was removed from contact with the mesh (by esterification). In this case, the further 
preparation of the fullerene for water solubility took long enough that the was essentially decayed by 
the time the fbllerenes were ready to be administered to the mice. As discussed in Section 2.2.4, several 
shortcuts in the synthesis appear possible, perhaps creating an opportunity for a d m i n g  a 
combination of medium and short half-life radionuclides with a single preparation. 
The encapsulation efficiency can be calculated from the washing data. For example, 1.50 pCi of u4Ra was 
electroplated onto a certain Pt mesh. The fullerenes then coated it for 18 hours. The amount of 212Pb 
created during this time can be readily approximated using the relation AD = Ap[l-exp(-.693*t/~l/z~)], 
where AD is the activity of the daughter (212Pb, e.g.), Ap is the activity of the parent (150 pCi), t is the 
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time (18 h in this case), and TIN) is the half-life of the daughter (10.6 h for 212Pb). The equation solves to 
be 104 pCi. 
3 4 
Wash # 
6 
Figure 6: Successive washings of 213Bi@C6~ malonic ester derivatives in ethyl acetate with dilute nitric acid 
containing cold bismuth atoms. "Calculated" is how much 213Bi was actually inside of the fullerene at the 
times the washings were performed, back calculated fkom the 33 nCi that did not wash out during the last 
wash. 
In this case, there were 220 nCi of 212Pb@C~ esters in the EA after exhaustive washings. The 
derivatization and washing were performed over 6.5 h (other experiments were in progress 
simultaneously). Using A = A,,[exp(.693*t/z~-2)] with A,, being the activity at the end of the contact 
period, A = 220 nCi, t = 6.5 h, and zln = 10.6 h, it is found that A,, = 336 nCi. The encapsuation efficiency 
is therefore 0.336/104 = 0.32%. Using the same method, we obtained a range of values between 0.1% and 
OS%, presumably varying according to the Cm film quality and the purity of the electroplated material. By Preparing more uniform films of both the parent radionuclide and the fullenme, it should be possible 
to increase the efficiency to 1 - 2"/0, based on analogy to implantation of lanthanides into fullerenes 
foIlowing neutron activation. 
3.2.2 Control Experiment: Washiag of Esters Witb Very Short Contact Time To ensure that 
the radionuclide signals fhm the EA after exhaustive washing are from the fullerene ester, a control 
experiment was performed. A mesh covered with 5 1.9 pCi 224Ra, 38.3 pCi 212Pb, 47.0 pCi 212Bi, 62.7 pCi 
22sRa, 276 pCi ulFr, and 288 pCi 213Bi (as well as -270 pCi 22sAc, presumably) was covered with (260, 
counted in the spectrometer to obtain those values and then put through the same ester derivatization 
process as before. The total contact time between the C ~ O  and the radioactive mesh was 25 minutes. 
10 
n n 
- 
m 212Pb in Ethyl Acetate  m '"Pb in Aqueous 
1 2 3 4 5 6 7 8  
Wash # 
Figure 7: Successive washings of 212Pb@C~ malonic 
ester derivatives in ethyl acetate with dilute nitric acid 
containing cold lead atoms. 25 minute contact time. Note the change in scale versus Figure 6Error! 
Reference source not found.. 
The EA was washed exhaustively, with the "'Pb data shown in Figure 8Figure . Clearly, some 212Pb 
remained in the organic, 2.8 nCi. Back-calculating gives 3.6 nCi at the time of esterification (3 h). 
However, it was also calculated that 51.9 pCi of 224Fb produces 1.38 pCi of 212Pb during 25 minutes. 
Thus, the encapsulation efficiency is 3.6/1380 = 0.26%, very much as expected. Similar data was 
obtained for 213Bi, with 26 nCi remaining after washing, giving 450 nCi at the end of the contact, and 87 
pCi produced from 276 pCi of parent during the soak, for WI encapsulation efficiency of 0.52%. Again, 
this is in line with expectations. 
To conclude, the amount of activity found in the organic phase after exhaustive washing with cold atoms 
in acid varies according to the contact time between the fullerene and the parent radionuclide in a 
predictable manner. The esterification chemistry does not cause the radionuclides to become soluble in 
EA or toluene. Although some hot atom may be suspended in the organic, they can be removed via 
washing with dilute aqueous acid. These results can be in t ep ted  to conclude that the radionuclides 
remaining in the organic solvent af€er washing are in a location that cannot be accessed by the aqueous 
solution during vortexing. The only such location lcnown to exist in this system is inside of the lllerene. 
3.23 Direct Recoil into Esters Tow& the end of the project, it occurred to us that perhaps we 
should try to recoil the daughter radionuclides directly into the lllerene esters. While this would save 
only a small amount of time, it paves the way for recoil directly into the fullenme acids, which could save 
several hours, depending on the work-up required to m o v e  exohedral radionuclides. Also, a specific Cm 
ester (one with six malonic esters, for example) could be used to coat the mesh, resulting in a more 
homogenous product. 
A mixture of Cso Binge1 esters (primarily those with 4, 5, and 6 malonic ester groups) was prepared, 
giving a deep ted EA solution. This was then air brushed as before onto a Pt mesh containing 41 pCi of 
224Fb and 52 pCi of u5Ac (amongst other radionuclides in the u4nzsRa decay chains). The ester-covered 
mesh was left to sit in air for 15.0 hours, then placed in a scintillation vial and gently vortexed (-600 rpm) 
in 1.0 mL EA. The vial and syringe were washed with an additional 0.2 mL EA, which was combined 
with the first mL in a centrifuge tube. Another 0.5 mL was added to wash, but was basically clear and not 
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retained. The EA volume was reduced to 0.7 mL under flow of N2. The EA solution was then washed as 
before, with the activities present in each washing M o n  shown in Figure 8Figure. 
0 I 
- 212Pb in Ethyl Acetate - 2 1 2 ~  in Aqueous  p'FrinEthyiAeetate  - "lFrinAqwous 
2 3 
wash# 
4 5 6 
Figure 8: Successive washings of 2'2Pb@C~ malonic ester derivatives in ethyl acetate with dilute nitric 
acid containing cold lead atoms. Removal of zzsAc atoms not recoiled into the 
demonstrated. The average time between washes is six minutes. 
cage is also 
Using the same calculations as before, it was found that the encapsulation efficiency for 212Pb was 0.15%, 
and that for 2'%i 0.36%. Although these are at the low end of the range of encapsulation efficiencies, the 
deviation is not statistically sigaificant It is interesting to note, however, that it appears to be more 
difficult to wash out the exohedral radionuclides than for the normal process. Somewhat Surprisigly, it 
therefore appears possible to recoil an atom into a fillenme derivative without greatly disaubing the 
exohedral derivatktion of the fillerene. 
3.2.4 The Fate of the 212Bi From 2nPb@Ca Malonic Ester Derivative6 Certain reports in the 
literature suggest that the Cn fill-e cage mild sometimes withstand a beta decay from an endohedral 
atom (Kikuchi et al., 1994, Sueki et al., lW), but not all the time (Sueki et al., 1998). However, their 
criterion for "stability" appeared to be whether the Cn fidlerene remained soluble m toluene-like solvents 
following beta decay. It is now h w n  (Diener and Alford, 1998) that most endohedral me&dlofillerenes 
are insoluble, including many isomers of the Cn cage. It is therefore more likely that the beta decays 
resulting in "instability" merely result in an insoluble endohedral Cn. We did not, and still do not, believe 
that it is possible for the weak recoil enerw associated with beta decays to remove an endohedml atom 
from a rllerene. One of the potential advantages of the fidlerene for "'Pb versus chelaton is that the 
fullerene will retain encapsulation of the daughter 2'2Bi. DOTA loses the *I2Bi 36% of the time (Mirzadeh 
et al., 1993). 
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The most likely explanation for this is that the 
shakeoff of electrons h m  the newly formed 
"'Bi atom sufficiently alters the electron Po 
distribution of the Ca so as to degrade the 
malonic esters responsible for the endohedral 
fullerene being soluble in the EA. While we 
cannot prove that the '"Bi is retained inside the 
hllerene, this seems a far more likely 
explanation than release of the 212Bi h m  its 
fullerene cage. 
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Figure 9: Comparison of "'Bi activity during washing to that of 212Pb. 
We were therefore fhstrated to consistently find more '"Bi in the aqueous portion following a wash than 
2'2Pb (Figure 9). So a particular aqueous .firaction was counted repeated, and the decay of '12Bi activity (as 
measured by the 583 eV photon intensity decay) was recoded (F4p-e IO). It was found that activity can 
be curve fit by plotting the decay of activity from '"Bi and a little "Pb in the solution. From these data it 
was determined that 36% of the "'Bi is not retained in the organic. 
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certainly be fat slower than the rate of fiee 212Bi escape. A significant portion, if not all of the 2'zBi@c, 
may still decay inside of the target cell. Thus, while this is obviously not the most d e s i l e  result, it is 
also not certain to be particularly detrimental either. 
3.2.5 Conversion of the Ester to the Acid Having washed away 
all radionuclides external to the lllerene ester (Section 2.2.1), the ester 
was now ready to be converted to the water-soluble malonic acid 
derivative. The basic procedure is given in Figure 11. The EA 
containing the ester was t r a n s f e r r e d  to a -10 mL flask which would 
serve as the reaction vessel for the hydrolysis. A stream of NZ both 
purged the flask and evaporated the EA. About 4 mL of toluene was 
added to 1-2 mg of NaH under inert conditions to form a slurry which 
was then added by syringe to the purged flask. This flask, still under 
N2, was immersed in a water bath, stirred, and heated to -80 C for 
about an hour. It was then removed fiom the bath, and MeOH was 
added immediately but very slowly. The d o n  of the MeOH with the 
NaH causes much hthing, even with a tiny drop. Methanol addition 
was discontinued until the fiothing subsided. Suddenly, after the 
addition of ca 0.2 mL. of methanol, a red precipitate fonns and the 
toluene turns clear. Methanol addition and stirring can be discontinued 
at this point. 
The toluene was then removed and analyzed for radioactivity, then -1 
mL, of deionized water was added to the flask, which immediately 
dissolves the precipitated l l l e m e  acid. The water was t r a n s f e r r e d  to a 
centrifbge tube, and the solids spun down. Assay of all three portions 
revealed yields between 55 and 75% for the 212Pb Illerenes, with -7% 
left in the toluene and insoluble material. 
Bucky Ester in Ethyl Acetate 
1 
Evaporate Ethyl Acetate Witt 
Inert Purge 
Add ToluenelNaH Slurry 
1 
Heat to -80 C for -1 h 
1 
Add Methanol Until 
Precipitation (-0.2 ml) 
Syringe Off Toluene 
i 
1 
Add Water to Dissolve Na + Ss 
of Fullerene Acid 
1 
Centrifuge to Remove lnsolub 
Material 
Figure 11: Process for 
conversion of the ester to the 
carboxylic acid 
At this point, the water is extremely basic, pH -14. While this can be 
neutralized with acid, that leaves a lot of salt in the solution, which proved to be detrimental to the mice 
(Section 2.3). The process was improved upon by adding 6M HCl to ttK basic water, l l l y  protonating the 
lllerene acid, and causing it to precipitate. This was then spun down in an mini-dwm (the 
precipitate is very fine), and the acid s u p m m t  syringed off. MES buffer was then added to redissolve 
the Mlerene acid. The pH was then 4, so a little 1M NaOH was added to bring it up to 7. The 
precipitation b m  acid and re-dissolution in buffer proceeded with quantitative yield when the 
ultracentriifuge was used; but only 75% of the Merene acid was recovered with a standard bench top 
centrifuge (-3000 rpm). 
While it may be possible to perform an acid-catalyzed hydrolysis, shorten the heating time with NaH, or 
otherwise improve the synthesis, in Phase I we were more interested in minimizing losses to the available 
material. Since the R@Ca derivatives are now in water, the aqueous solution is very susceptible to 
picking up stray radioactive dust fiom glassware, needles, and other SOUIWS in the hood. Once batch 
became contaminated with % and daughters, and the contamhation could not be removed. The 
aqueous solution was passed over ion exchange columns containing s u l b  groups. First, a coarser 100- 
200 mesh column was used, but that removed less than 30% of the contamhtion. Then a 200-400 mesh 
column was used, but again, less than 40% of the umtamidon was removed. (The umtamidon 
removed was a s s 4  by counting both the aqueous solution and the column.) Gratiijhgly, less than 5% 
of the 2'2Pb rerraained stuck to the column, and perhaps that could have been removed with additional 
washing. We believe that the &xylic acid pups on the Illenme are arranged such that they can 
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chelate external metal atoms, and that this chelation is strong enough to compete successfully with the 
sulfate groups on the resin for both +2 and +3 metals! 
Although the low amounts of radioactivity available multed in non-optimum methods being employed to 
obtain three time points for the biodistribution, the mults are consistent with each other, and allow 
certain conclusions to drawn without doubt The biodistribution study unfortunately turned out to be a 
synthesis of two different batches of 2 1 % @ C ~  malonic acids. We fbt purposefirlly attempted a single 
time point, as a check on our chemical and analytical methods. However, trouble electroplating the 
224/22sRa (combined with the intrinsically low encapsulation efficiency) at the time we were set to pedorm 
the true biodistribution, resulted in less available activity, and scaling back the number of mice in the 
study. We therefore were f o d  to rely upon the one hour time point obtained during the initial trial. 
Since the methods varied slightly, each experiment is desclr’bed separately below, and then the data are 
collated in the third subsection. 
3.3.1 One Hour Study As the carboxylic acid derivatives of Ln@& (Ln = lanthanide) are 
a parently water-soluble down to pH -5 (determined from cold work at TDA), we assumed the same for 
2Pb@c,. Aiter adjusting the pH of the MES-b&d aqueous solutiom containing the 212Pb@C~ 
carboxylate to 6 - 7, we were ready to inject the mice. 
P 
The first time, we thought we would do a trial study using three mice and sacrificing at one hour, to test 
the procedure, the preparation of the firllerene acid, and the data collection mechanism. This first time, we 
dissolved the fullerene acid precipitate b m  methanol directly into MES, and adjusted the pH down to -7. 
Adjusting the pH required 2q5 ul of 2M HCl, followed by 20 ul of 8m HCl. We did not re-precipitate the 
lllerene acid. There were then 130 nCi of 212Pb@Ca acids in 750 ul of MES-buf€ered aqueous solution 
Two lOul aliquots were removed as standards for the gamma ray spedmxopy counting. For this test run, 
we had three female mice with severe combined immunmciencies (SCID) ready. 
200 pL of the solution were administered by tail vein injection to the first mouse, which promptly expired 
following injection. Dr. Kennel believed (and believed prior to injection, actually) that the salt 
concentration of the fullerene acid solution was too high for the mouse. There!fom, the fullerene solution 
was diluted with an equal part of deionized water, and two injections of 200 ul total volume each (where 
each injection contained 100 ul of the hllerene solution and 100 ul of deionized water) were made two 
minutes apart for the second mouse. Despite hunching and some impaired mobility, the mouse lived. The 
third SCID was also injected in this manner, but the injections wem made more slowly, the mouse 
exhibited less hunching. To obtain a third data point, the d g  125 ul of fullerene solution (diluted 
with 125 & DI H20) was administered in a single injection to a BALBIC mouse. 
The mice were sacrificed one hour after injection by cervical dislocation The fdlowing tissues were 
collected from each mouse and placed in previously tared plastic scintillation vials: skin, leg muscle, ’ 
femur and sternum (referred to as “bone” henceforth), stomach and intestines (which were emptied first), 
ovaries and uterus, liver, spleen, kidneys, heart, and lungs. Blood, including any available clots, was also 
Collected. 
The vials were then counted in a Wallac Wizard. The Wallac is far more sensitive than the spectrometer 
discussed on page 4, but lacks the resolution. It was preset to collect all photons emitted b m  the sample 
over two y-ray energy ranges; the first correspondin the 238 keV y-ray from 212Pb, and the second to the 
510 and 583 keV y-rays from 208Tl used to assess 2Bi. As there were no other radioisotopes present in 
the sample (determined by counting a few tissues on the spectrometer), there were no interferences. 
Tissues were counted for 10 minutes each. The 10 pL standards were also counted, as were blank vials to 
f 
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provide a background. The Wallac provides data in the form of counts per sample per photon energy 
range, along with the time that the counting was concluded. 
Subtracting the average counts associated with the blank vials from each of the tissue counts gave a 
record of counts per 10 minutes tissue for each isotope. Using the time stamp and the half life of "'Pb 
allowed the calculation of the Pb counts at the time of sacrifice for each tissue of each mouse. The total 
injected dose was calculated from the 10 ul aliquot counts, and the activity calculated from the counting 
the aliquots in the spectrometer. From this, it was determined that the first two mice received 28 nCi of 
212Pb, and the third mouse received 18 nCi. The vials were =weighed the followin day to determine the 
weights of each the tissues collected. Since it took so long to count the tissues, 21!& was either back in 
equilibrium with the '"Pb, or had decayed away. Deviations from equilibrium were well within the 
uncertainty in the 'I2Pb activity. The data was assembled into the biodistribution graph shown in Figure 
12Figure . Considering the variation in method of administration, the data are in reasonable agreement 
from mouse to mouse. 
2 1 F  
"F 
Figure 12: One hour biodistribution of 212Pb@C,[C(COO-)2],, including standard 
See text for details. 
error. 
3.3.2 Three Hoar and Eight Hour Biodistribations By the time in the project that we were 
ready to attempt the biodistibution study, we knew what the encapsulation etlticiency was, and, while we 
had experienced some problems with electroplating Ra, they had not been severe. Udortunately, during 
the days leading up to the biodistribution, it seemed that only -1Ph of the Ra in solution could be 
electroplated onto the mesh. (We had previously achieved 30 - 50%). It was decided to use three meshes, 
ester@ and wash the Cm coating each mesh, and combine the esters prior to acidification. As described in 
Section 2.2.5, we avoided the problem of excess salt (and base) by rsprecipitatins the fbllerene acid 
following the initial aqueous dissolution with 6M HCl, followed by ultracentr&gation, removal of the 
supernatant, and redissolution in MES (followed by a minor pH adjustment). However, there were only 
55 nCi of 212Pb@c,[C(COO-)& left for the mice. Thus, we were forced to back off some of the planned 
time points in order to have enough activity to do six mice well. 
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Six BALB/C mice received 200 ul of hllerene acids in MES by a single tail vein injection, 9 nCi per 
mouse. The mice did not exhibit an of the hunching or discomfort previously seen, and appeared 
u n & d  by the injection. Three mice were sacrificed at 3 hours post-injection, and the remaining three 
at 8 hours post-injection. The same tissues were collected as before, with the addition of collecting the 
urine expelled at the. time of death. The activities and tissue weights were assessed using the same 
procedures as for the 1 hour biodistriiution. However, certain tissues from the 8h mice were recounted 
the following morning for 30 minutes each on the Wallac to improve the signal to noise ratio. The tissues 
selected were those perceived to be the more important ones, namely bone, spleen, kidneys, liver, blood, 
urine, and stomach. The individual mouse biodistributions for 3h and 8h are shown in Figure 13 
Figure. 
75 r 
P s 
BBr .~ 
55-  
4 4 -  
33- 
22- 
11 - 
0 
Figure 13: Three hour (left) and eight hour (right) biodistributions of 2’2Pb@C~[C(COO~)2],. 
3.33 Average Biodiitribatiom; Comparison to Previous Studies 
biodistribution graph, the %D/g for each tissue were averaged for the three mice from each time point. 
The combined “average” biodistribution graph is shown in Figure 14Figure. Despite the unusual 
p r e p d o n  method, some conclusions can still be drawn with confidence from data 
To provide the usual 
Like other fullerene derivatives so far investigated, the malonic acids derivative also seems to accumulate 
primarily in the liver. By normalizing the counts from the liver to the 10 pL aliquots, it seems that about 
50% of the injected dose accumulates in the liver. We had hoped to avoid this with the carboxyhllerene, 
and achieve rapid clearance, but clearly that did not happen. Data recently presented at the Material 
Research Society Meeting on Dec 2, 2003 from Prof. Wilson’s group at Rice used dynamic light 
scattering (DLS) to assess the aggregate size of Gd@ca~ carboxyfullewnes prepwed at TDA Research, 
and found that the fullerenes aggregated significantly, even at pH 7. This may explain the accumulation in 
the liver. 
17 
70 - 
60 - 
50 - 
40- 
30 - 
20 - 
10 - 
0- 
n 
T 
E 
cn P 
= 1 hour = 3hours 
D 8hours 
Figure 14: Average biodistribution of 2'2Pb@C,[C(COO-)2], using the data presented in the previous two 
subsections. "Error bars" show standard deviation. 
The extra residence time in the liver was however usell since it demonstrabed that the '"Pb is not 
released to the bone, the target tissue for lead. The slight accumulation in the bone (2.3 at 1 h, 1.8 at h, 1.5 
at 8 h %ID/g) both decreases with time, and compares favorably to the previouS DOTA-Ab 
biodistribution study (Ruble et al., 1996, found 3.2 - 7.8 %ID/g depending on the targeting agent). Thus, 
whatever is happening to the fullenme in the liver (if anything) does not release the endohedral '12Pb. This 
is a crucial point, since DOTA-chelated "'Pb tends to result in severe myelotoxicity, presumably from 
freed '12Pb accumulation in the bone. A targeted 212Pb fullerene should have even less accumulation in the 
bone, as the targeting agent will direct the fullerene to a specific tissue. 
Amongst other tissues, clearance h m  the blood and kidneys is demonstrated, indicating that the free 
212Pb@C,[C(Coo')& cleam from circulation on a time scale corn- with the half life of 212Pb. 
Significant accumulation in the spleen is also noted, again, a possible mult of aggregation. Doses to other 
tissues are low; the free carboxyfullerene does not target any of the other tissues sampled. 
The chemistry developed on this project is c l d y  a significant improvement over the only previous 
endohedral radiofullemne biodistribution study (Cagle et d., 1999). The authors of that study prepared a 
polyhpxylated '%o@C, by neutron activation of the '-0. The polyhydroxylated radiofullerene 
obtained 8% ID/g bone, and uccumuZuted over time. They also observed very high doses of the lllerene 
in the liver, which cleared slowly, and similarly low doses with significant clearance h m  the other 
tissues assessed in this study. From our preliminary study, it appears that the malonic acid derivatkition 
is superior to polyhydroxylation for radiofullenmes. 
The most important part of the biodistribution study is that the fke 212Pb@C~ derivative does not 
accumulate in the bone. Therefore any catabolism, or any other biological pmcess that competes for Pb, 
will not result in uptake of in bone h m  the endohedrd Merene 212Pb@C,jo. This use of the 
fdlerene is so far the only known method to prevent 212Pb uptake in bone, and will presumably mitigate 
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the myelotoxicity that plagued earlier studies (Ruble et al., 19%; Horak et al, 1997) and has so far 
prevented the further development of "'Pb radiopharmaceuticals. 
3.4 Summary of '12Pb Studies 
The primary achievement of thii part of the project was that incontrovertible evidence was obtained for 
the production of 2'2Pb@C, via recoil implantation following a-decays in the 224Ra chain. We also 
established a rapid protocol for the chemical derivatization of the hot endohedral fullerene, leading to a 
robust, non-aggregating water-soluble radiofullerene derivative that is easily separated from both hot and 
cold unencapsulated nuclides. Although the fullerene did not show improvement vs. chelators at 
containment of the "'Bi daughter, the fullerene does unequivdlyprevent leakage of the bonetargeting 
Pb. This is the key requirement for further development of 12Pb for RIT that has not yet been 
surmounted by chelation techniques. In summary, we have demonstrated the promise of the a-recoil 
implantation technique for producing radiofullerenes suitable for pharmaceutical development, met only 
readily surmountable hurdles, and remain enthusiastic about the continued development of the technique. 
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4. Implantation of '=Lu by Recoil Following Neutron Capt~re 
The third method pursued in this project uses the energ from the recoil following neutron absorption to 
implant the activatved atom into the fullerene. Depending upon the isotope, the energy of the neutron 
capture reaction is usually between 5 and 7 MeV and is radiated as y-rays. Upon emission of a 7-ray, the 
nucleus recoils with energy -120 eV (for lanthanides with an average mass of -130 mu). As the nucleus 
recoils through the firllerene lattice it can eventually break open a fullerene and become trapped inside. 
The large number of vibrational modes in the lllerene rapidly redistributes and dissipes the collision 
energy, thus allowing the ruptured bonds to ref- This techniques has been used for Be (Ohtsuki et al., 
1994), "Ar (Gadd et d. 1997,1998; Braun and Rausch 1995), various Xe and Kr isotopes (Gadd et ul. 
1997), '% (Rausch and Braun, 2001), and %e, nAs, 75Se, lrn, '%b, and 121Te, (Ohtsuki et d. 2000, 
2001, and 2002), ahhough it is ditlicult to determine whether the p-electron atoms am inside of the 
fullerene or have become part of the fullerene cage. Of particular interest, the experiments performed by 
Braun and Rawch (1998) appeared to demomtrate that it is possible to produce significant yields of 
radioactive metallofullerenes by irradiating mechanically homogenized mixtures of Cm and metal oxides 
of Cu, La, Pr, Ho, and Zn. By dissolving the product in aniline and subsequently extracting the aniline 
with aqueous acid, the authors conclude that a significant fkaction of the activated metals become trapped 
inside the Cm durin the activation process. The roduction yields calculated by the authors are 63Cu + 
'%u Cm (9.0%), ' k a  + I4OLa@Cm (14.5%), "br + '''Pr@C~ (31.1%), 1 6 5 H ~  3 '%o@C60 (3.6%), 
and '*Zn + 654*Zn@C, (9.1%). These results are in general agreement with our previous results 
(Thrash et al, 1999), which examined the escape of activated '&Ho from inside pre-synthesized 
165H@C82. However, the results from this part of the project raised serious questions concerning Braun 
and Rausch's procedures and results. 
We selected lnLu for s e v d  reasons. The advantages and disadvantages of 17'Lu use in RIT were 
discussed in the original reprt of its use in a radiologic immunoconjugate (Schlom et al., 1991). Its long 
6.7-day half-life provides ample time to develop the requisite purification and derivatization p d u r e s  
without substantial loss of activity or large drop in specific activity. The ability of the fullerene to 
encapsulate the radionuclide with zero in-vivo loss is always important, but is even more crucial for a long 
half-life radionuclide. Current chelates such as DOTA perform very well, but as the half-life increases, so 
does the chances that transchelation will eventually release the radionuclide. Free lanthanides such as 
177Lu, ''%Io, and 9 strongly target bone where they i r r a d i i  the bone marrow, and in many cases this is 
the dosaliiting factor. The stringent requirements for chelation were considered to be the primary 
disadvantage for lnLu development in the Schlom publication, and the fullenme is the best choice to 
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barns while 0'176 = 2090 barns, Mughabghab et al. 1981). Because of this large difference and the high 
cross section of 176Lu, activating a mixture of naturally occurring Lu and Cm should provide encapsulated 
' 7 7 ~ u @ ~ a  with both high activity and high specific activity. While the primary pathway for formation of 
'"Lu@Ca is activation of 17%u, our model includes 
all of the known reactions. To eStimrrte the '"Lu-Cm trapping efficiency, we used the lowest 
encapsulation value reported by Braun and Rausch (3%). The efficiency of keeping the previously 
encapsulated 17%u in the Mlerene during activation is estimated at 25% based Thrash et d. (1999). 
Survival of the beta decay of '"Lu to '"€His assumed to 1W/o as reported Kikuchi et al. (1994). 
The reaction equations were formulated into series of simultaneous ODE'S that were subsequently solved 
by numerical integration to yield the concentration of each of the species in the model as a function of the 
irradiation time. For our test model, we assumed that 100 mg of Cm (1.4~10~ mol) was mixed uniformly 
with a six to one ratio of Lu to & (a reasonable value for Ca intercalates), and that this sample (600 mg 
of natural Lu& 6:l ratio of Lu to k) would be M a t e d  at the HFIR's pneumatic tube one facility, 
which has a neutron flux of 2.3~10'~ n Set' The estimated yield and specific activity of 177Lu@C~ 
predicted by the model are shown in Figure 15Flgnre . It is d l y  apparent that '"Lu@C, with an 
activity of almost 1 Ci can be easily obtained even for this relatively small -le that is i r rad id  in a 
low flux position of the HFIR The specific activity, expressed as the percent Purity of the '"Lu@C, 
can vary between 70 and 85% depending upon the desired activity, a value that is certainly acceptable for 
radiotherapy. We believe that this calculation illustrates our point that high activity and specific activities 
k, = 0.97n~a,,~,, k2 = 0.97n~a,,~~, 
k3 = 0.03n~c~,,,~, 
k7 = 0.03n~o,,~, 
1nLu + broken C, 
'76LU@C, 2- 
3- '77LU@C, 
k4 = 0.75n~c~,,,~,, 
k5 = 0 . 2 5 n v 0 , ~ ~ ~ ~  
Figure 15. Kinetic model for the production of i77Lu@C, by recoil implosion in a nuclear reactor. 
Where n is the number of Lu nuclide in the target, and v is the flux density of thermal neutron 
can be readily attained by the recoil method (assuming the data in Braun and Rausch, 1998, is accurate). 
If commercial production was requid it would be relatively easy to irradiate a sample 100 times larger 
than this at the high flux position of the HFIR, which has a flux of 2xIO'' n sec-' cm-'. 
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4.2 Neutron Activation to lnLa in Mixtures of Lutetium M e  and Ca 
This section begins with a brief description of the HFIR, and the techniques employed there to produce 
'77Lu in our samples. It then presents results h m  activation of the Lufi  - Cm mixtures. Since Braun 
and Rausch (1 998) apparently achieved excellent results from mixtures of metal oxides and C~O, we felt 
that our investigations would use the same technique. 
4.2.1 Neutrons From tire HFIR 
The HFIR has a variety of different facilities, at different fluxes and fbstlepihmmlbmd neutron 
content. Since we are solely in- in thermal neutrons, and low fluxes are suflicient for the p r O o f -  
concept experiments undertaken in Phase I, we used the lowest flux positions on the HFIR, the pneumatic 
tube facilities of the neutron activation laboratory. Two pneumatic tube facilities, designated PT-1 and 
PT-2, are available in the HFIR These facilities, operated by the ORNL Analytical Chemistry Division, 
consist of flight tubes, air supply and exhaust lines, loading stations at which sample containers (rabbits) 
are introduced into the flight tubes, and irradiation stations to which the rabbits move to be irradiated (see 
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Figure 16. Integrated rate equations yielding the total activity of '77Lu@C~ and the specific 
activity of ' n ~ u @ ~ a o  as a function of the irradiation time, The specific activity is ca~culated as 
the percent of 'vL@,C~ relative to all endohedd CHJ species produced. 
Figure 17Error! Reference source not found.). The h e r  diameter of the flight tubes is 0.62 in. (15.88 
mm), and the outer diameter of the rabbit is 0.56 in (14.48 mm). Both flight tubes accept the same 
rabbits, which have an intemal volume of about 1 an3. Both systems operate with air entering both ends 
of the flight tube. Capsules are insated into the reactor and returned to shielded loading stations in the 
laboratory. The capsules stop on air columns, which permit them to be made of graphite as well as plastic. 
The capsules can be stopped at decay stations in the p l  ifthey are temporarily too radioactive to return 
to the laboratory. 
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PT-2 is located in a slant engineering facility 
that intersects the outer edge of the 
permanent beryllium reflector. (The Be 
reflector forms a shield around the core.) 
This places the irradiation station 
approximately 12.5 in. (32 cm) from the fuel 
element. The thermal flux for the facility is 
thmallepithermal ratio is approximately 
200, minimizing damage to the fullerene 
shell. 
Unfortunately, the HFIR was shut down for 
administrattive reasons for the bulk of this 
project. mle the HFIR had previously Figure 17: PT-1 of the HFIR PT-2 was used to neutron 
1986 without aCtiVate the Samples, and they are Similarly designed and 
shutdown (except to change the fuel), located- 
multiple administrative shutdowns since then have occurred, and this project had the unfortunate timing 
of nearly coinciding with one the longest. Once the system was restarted, howevery the neutron activation 
team was able to irradiate and return samples of varied chemical composition in a prompt and efficient 
manner. (It is likely that our samples received something of a priority status during this time, as we made 
the project’s time constraints known to them.) 
IIIIW- about 5.9 x 1013 neutrons/(cm2.s). The m I I 1 R i l l t l l l i . r  
-mTn 
-yuI 
Umu- 
o.IIII*pImaimLIw 
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from 1966 
The implications of the extended downtime of the HFIR for this project were that we had to irradiate 
many samples more or less at once, often without knowing the results of the previous irradiation. This is 
a relatively inefficient experimental method, compared to a sequential plan of experimentation. In 
analyzhg the data, it became clear that some opportunities were not capitalized on. Nevertheless, we will 
show in the following subsections that sufficient results were obtained to validate the central conwts of 
the project, namely that mil implantation is an attractive method for production of medicinally usefbl 
radiofullerenes. 
4.22 Irradiation of Natural La&h - CCO lwixtares 
The pmcedum of Braun and Rausch (1998) served as a starting point for our investigations, as they 
claimed >3% of the activated metal became implanted inside of GO during their irradiations. They 
mechanically mixed naturally occurring metal oxide powders with GO and subjected the mixture to a 
neutron flux of 1.95 x 1013 n/cm2/s for 12 h. At TDA, l5Omg of each Cm and Lu~03 were placed in a 
plastic vial ?4” diameter by 1” tall. About 7 alumina balls %” in diameter (mini grinding media) were 
added to the container. The container was then vibrated at high speed for 30 seconds, producing a 
uniformly brown, fine powder. Without the mini-media, the black Cm and white oxide grains did not mix 
well, resulting in a salt-and-Wper like powder. 
Three samples were created from the brown powdery with weights 1.5 mg, 2.0 mg, and 3.0 mg. The 
samples were weighed out into lidded polyethylene containem and were all placed in a rabbit. The rabbit 
was irradiated for 20 min in PT-2 with a flux of 5*1013 nlcm2/s. Following irradiation, the samples were 
allowed to cool for several days. 
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Each of the three samples and containers was moved  fivm the rabbit, placed in separate vials, and 
counted individually in a gamma ga spectrometer. A typical gamma ray spectrum is shown in Figure 
18Figure . The two prays from ' 7Lu are clear and distinct, without contamination. Although the 
ordinate is given normalized in arbitrary units in the figure, the data is taken as counts with a resolution of 
0.5 keV per channel. Since the gamma ray energies are actually a few channels wide, the software 
7 
calculates an area under each peak. The activity of 
the samples is then calculated by dividing the area of 
each of the peaks by the counting time, the detector 
efficiency as a function of the shelf and the gamma 
ray (previously determined by calibrated staudard), 
and the probability of the gamma ray occurring 
(0.066 for the 112.95 keV photon, 0.110 for the 
208.36 keV photon) to give activity in decays per 
second (dps). Where necessary, the dps values for the 
two hotons were averaged to give a single value for 
the Lu content of the sample. Since dps is a 
somewhat cumbersome unit, it was divided by 
3.7* 1 o4 to give a value in microcuries (pci). 
Pn 
The initial activity of each of the samples was 
calculated fivm A, = A/exp(-ht), with A representing 
the activity at time t, and h the decay constant = 
I O  r 
.693/half-ife). The initial activity pei mg of Lui03 Figure 18: Gamma ray spectrum of the 3.0 mg 
was then obtained for each of the samples. Thus it LuzOJ/C~O mixture 4.5 days after irradiation for 20 
was determined that 433, 457, and 459 pCi lnLu min in PT-2. 
were obtained per mg of natural lutetium oxide (average = 450) for 20 minutes of irradiation in PT-2 for 
the 3.0 mg, 2.0 mg, and 1.5 mg samples respectively. 
4.23 Activation of '76Lpzo, - C, Mixtures 
We also prepared and irradiated mixtures of 70?? enriched '76Lu~03 and Cm. 176Lu is quite expensive 
(J17Umg) and only a few mg were readily available at ORNL. Mini-ball milling could not be used to 
prepare samples, as either a great percentage of the "6Lu would end up stuck to the grinding media, or the 
Therefore, a 
method was devised, whereupon the 176Lu oxide was sonicated into a known volume of acetone, which 
was subsequently divided into two portions. One mg of Cm was ackled to both portions, and they were 
placed into polyethylene containers suitable for irradiation at ORNL with internal volume -0.3 mL. The 
Containers were them held in an ultrasonicator bath without lids and s o n i d  until all the acetone was 
removed. Since neither Cm nor lutetium oxide are soluble in acetone, the sonication is another physical 
method of mixing. The 70% emiched 176Lu samples were irradiated for only 2 minutes in PT-2, resulting 
in initial activities of 110 pCi each. 
6Lu would be so dilute in the fullerene so as to be disadvantageous during work-up. 7 
4.3 Assessment of the Recoil Formation YieM of 'RL~@C, 
At this point, the sample consisted of Cm 177Lu@C, and Lu203 with a variety of Lu isotopes, including 
'77~u.  he next issue was to deter mu^ - the portion of ' 77~u  that was encapsulated in G. since both the 
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'77Lu@C~ and the Lu*@ are insoluble, we detedned to first subject the e n h  sample to malonic 
esterification, as described in Section 3.2.1. As the esterification reaction renders the 'nLu@c, soluble, 
it provides a handle to sepamte the fullerenes from the oxide. Following the esterification reaction, the 
solids were removed, and the soluble portion was washed exhaustively with 0.12 M HNO3 containing 
- 1 ~ 1 0 ~  M Lu'~ ions to m o v e  any trace lnLu left in solution but outside of the fiillerene. At this time, it 
was discovered that the yields w e ~ e  much less than reported by Braun and Rausch (1 998), though there 
was unquestionably some 'nLu@C~ implanted in the Illerene. Section 4.3.3 discusses why their data 
cannot possibly have been correct, and points to a p u p  of relatively simple solutions that were partidly 
explored, as reported in Section 4.3.4. We concluded that the recoil implantation method works well, but 
that the material to be irradiated must be prepared far more careklly than was reported by Braun and 
Rawh. 
4.3.1 Results of Malodc Ester Derivatizrrtion and Washing 
The results of exhaustive washing of the 2.0 mg natural L u ~ a  - C ~ O  sample, derivatized to become 8n 
ester, are shown in Figure 19Figure . Clearly, the activity in the aqueous portion falls off rapidly, while 
the activity in the organic comes to an equilibrium after 6-7 washes. The activity in the Il leene portion 
levels off at about 3.0 nCi. Back-correcting this number to 8ccount for the decays occurring during time 
that sample was prepared shows that 6.0 nCi were originally present in the fullerene. Since the sample 
originally contained 450 pCi, however, the yield ('77Lu basis) is only 0.0013%! This is far lower than we 
were anticipating, and severely lower than reported by Braun and Rausch in 1998. 
I 2 3 4 5 6 7 8 
Wash 
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Figure 19: Washing the bucky ester with an aqueous Lu - nitric acid solution. Error 
bars are from the uncertainty in counting data. See text for details. 
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4.32 The Fundamental Problem with Recoil Formation of Radiofnllerenes From Mixtures With 
Metal Oxides 
The explanation for the appamtly low yield h m  the Lu oxide experiments lies in the lack of proximity 
between the fullerenes and most Lu atoms. We were trying to mix grains of Cm with grains of Lu203. A 
quick calculation demonstrrrtes the problem. 
Grains of metal oxides are typically between 1 and 10 microns in diameter. Since no special effort was 
made to make the Lu~@ grains small, the assumption of a two micron grain is entirely reasonable. 
However, a heavy nuclide l i e  Lu will only recoil a distance between 0.5 and 1 nm in a solid following a 
(n,y) reaction (Lieser, 2001, for example). Again we will take the conservative case of the activated Lu 
nucleus recoiling 1 nm. Therefore, it is only the atoms on the outside of the grain that have a chance of 
encountering a fullerene during recoil. Since the atoms inside of the grain tire as likely to be activated as 
those on the outside, however, the portion of the activated nuclei that encounter a fullerene during recoil 
is only a small percentage of the nuclei that become activated. 
Assuming spherical grains of Lu2O3 with diameter 2 pm, the portion of the Lu atoms in the outermost 1 
nm shell can be calculated as the ratio of the volume of the outer 1 nm shell of the 2 pm sphere to the 
volume of the 2 p sphere; i.e. ( l3 - .999) / l3 = 0.3%. Thus, only 0.3% of the Lu atoms could recoil out 
of an average size oxide grain. However, grains tend to agglomerate, and physical mixing methods can 
not overcome this tendency. If we assume that 1/3d of the grain’s surface interfiua with a fullerene, then 
only 0.1% of the Lu atoms even have a chance to encounter a fdlerene during recoil. 
If only one in a thousand InLu atoms even had a chance to become trapped within a Illerene, then our 
yield calculated h m  the ratio of lnLu activity in the fullerene ester to the total lnLu activity (0.0013%, 
Section 3.3.3) in the sample does not appear so bad. We conclude that 1.3% of the activated Lu that 
could have encountmd a fullerene became entrapped. Thus, if we could bring the Lu atoms and the 
fullerem closer together, mixed on a molecular scale, then the yield could increase a thousand fold, into 
having a few l7’Lu@cs0 per hundred 17’Lu atoms. Such a sample would genende a 10 mCi dose while 
having only 1 Ci total activity, and the other 990 mCi is d y  moved  at the outset. Indeed, our result 
of 1-2% of the neutron-activated lnLu that had a chance to recoil into the fullerene fonning an endohedral 
l l l e m e  is very encouraging. 
Though Braun and Rausch (1998) calculated 3% or greater yields fkbm the same experiment, with the 
same physical limitations, it is clearly impossible, and we can offer a possible explanation for their error. 
Following irradiation, they extract the fullerene sample with aniline. The primary amine M o n a l i t y  on 
aniline readily fbnas chargelransk complexes with a wide variety of electron-poor materials, including 
empty fullerenes, metallofbllerenes, and possibly hot lanthanide ions that lost electrons as the gamma ray 
was emitted. Common chelators for radionuclides (EDTA, DTPA, DOTA, etc.) me a h r  all just amines 
sepamted by ethyl groups. Thus they observe a lot of activity in the aniline, even though most of the 
activity is not in a fdlerene, but “chelated” by the aniline amine. They then extract the sample with acid, 
but there is no cold Lu in the acid Without cold lanthanides in the wash, there is no exchange between 
hot and cold lanthanides, and the aniline mtains its hold on the hot lanthanide. It is therefore not 
surprising that they found no hot lanthanide in the acid part of the wash. Whether this is the reason or 
not, as they may have made other errors impossible to discern without directly observii their 
experiments, their claim of 3% yield h n  mechanical mixing of l w d e  oxides and CSO turns out to be 
absolutely impossible. Fortunately, there are ways to fix this fundamental problem, specifically by 
avoiding oxides and by mixing by chemical instead of physical means. 
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or less remained in solution following 
centrifugation. A set of three washings removed 
4.33 Avoiding tbe Fundamental Problem: Preparation and Activation of Non-oxide Ln - Ca 
Mixtures 
We first tried to improve the mixing by co-pmipitating C ~ O  and Lu(l72-pentandonate)3 [also known as 
Lu(acacb] fbm various solvents. Both are soluble in xylene, and a mixture of 2 mg each acac and C ~ O  
was stirred into 4 mL xylene. The xylene was then removed under flowing gas down to the last 0.5 mL, 
which was transferred into a polyethylene activation container. The final xylene was removed with 
flowing gas, but the result was unsatisi'jing: the upper wall of the container was coated with a black 
substance, presumably the CSO, while lower part of the container wall was coated with a light brown 
material, presumably the acac. 
t 
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Though the solubility differences in xylene were too large for a co-precipitation method to work, perhaps 
a different soluble would be more suitable. Two mg of both C ~ O  and the acac were then dissolved in 
dhnethylformamide (DMF) and stirred. The DMF was then removed under vacuum, although it is very 
difficult to completely remove the high-boiling DMF. The flask was maped, and the recovered sludge 
was placed in a sample container. The sludge was activated in PT-2 far 20 min, and left to mol for a day. 
Though clearly on the right track, the DMF method could still be less than optimum for several reasons. 
Even though the sludge appears uniform, microcrystals of Lu(acac) and C ~ O  could still form during 
evaporation, similar to the experience with xylene. It is also possible that the DMF forms chargs-transfer 
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complexes with Cm andor Lu@Cm. Though these ought to be broken by the action of the hydride on the 
C- it has never been studied. Significantly reducing the esterification d o n  yield would appear as a 
reduction in recoil implantation yield in our calculation, since we are calibrating off of the portion that 
eluted through the WLC as an ester. We have by no means exhausted the list of solvents potentially 
suitable for cm-precipitation mixing of Cm and LNacac), and the encouraging result versus the oxide 
suggests that further work is warranted. 
It is possible that the optimum solution was to mix the fullerene with the lutetium at and atomic level, i.e. 
prepare a Lu,Cm salt. FUnerene salts of certain lanthanides are known, specifically those with Sm (Chen 
either superconductors (Sm , Yb) or fhmmagnetic (Eu). Given their intemsthg solid state pmperties, it 
is, at first glance, surprising that no other lanthanide salts have been reported. The reason is that, amongst 
lanthanides, Sm, Eu, aod Yb have by far the greatest vapor pressure (Figure 21Figure ) and therefore most 
prone to undergo solid state reactions. These salts were prepared by simple heating with C ~ O  at ca. 600 C, 
with d o n  times varying h e m  hours and weeks. All authors report a narrow temperaaue range 
through the reaction occurs without decomposing the 
Cm would decompose at any temperatwe when the 
reaction proceeds at a measurable rate. 
and Roth, 1995), EU (KSari-Habde~ et al., 1997), and Yb (0- et al., 1995). These cOmpOundS are 
Cm. Sadly, Lu has a rather low vapor pressure, and the a- 
Other fidleride salts have been prepared with Group I 
and I1 metals, since they also have high vapor pressure 
(relative to other metals). These have also found to be 
superconducting, sparking a flurry in interest in their 
preparation. Electrochemical methods are prone to 2oo- 
contamination by counter ions, which usually contain 
halides, which are forbidden from the HFIR's 
pneumatic tubes. However, Chen et al. (1 997) offer an 
Figure 21: Enthlapies of Sublimation for the 
Lanthanides (Cotton and Wilkinson, 1988). 
interesting preparation of RbCm at room temperature. 
The authors mixed Cm powder and Rb powder in a 
flask with propylamine as the sole liquid. The propylamine readily forms charge transfer complexes with 
the Cm, and a tell-tale green solution. This complex is subject to reduction by the Rb, forming an Rb-C~O 
salts which precipitates. The amine is then removed under vacuum. 
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Although Lu is -0.6 V less pow& a reducing agent than Rb, we thought to try this reaction. In the dry 
box, 36 mg Cm and 8 mg Lu (40 mesh) weie added to a 3-neck 5OmL flask. The flask was removed to a 
Schlenk line, to which 25 mL of degassed propylamine was added, and the d o n  stirred Vigorously. 
We also thought to try a tertiay amine, which might be easier to remove. To that end, Cm and Lu were 
added to DBU in the dry box. Both reactions took on a green color within hours. Afbr several days, 
metallic Lu could still be seen at the bottom of both flasks. However, the propylamine reaction had lost 
its green color, becoming brownish-red, as predicted by Chen et al. The DBU reaction temained green, 
and was not pursued fixher. 
The propylamine was removed under vacuum, and the recovered solids were split in two to create two 
samples. They were both irradiated for 20 min in PT-2. After several days' worth of cooling off, their 
gamma ray spectrum was similarly clean as that in Figure 22Figure . Addition of the THFNaI-I slurrly, 
however, resulted in a green solution, some of which was set aside. The THF of the set aside portion was 
removed, and xylene was added, creating a brown solution reminiscent of the ester. Washing of the THF 
portion caused a precipitate, while washing the xylene was rather slow, but ultimately resulted in 
complete loss of activity fiom the organic. In summary, the presence of lehver propylamine, with 
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unclear charge states on the Mlerenes, caused the esterification &on to veer off, at least partially, into 
unknown products. 
Probably the optimum method to prepare ‘nLu@Cm is to mix isotopically enriched 17% with Cm, heat 
to 600 C to form the Yb&m salt (after Ozdas et al., 1995), and activate that salt. The reaction 
is in fact the common process to make 177Lu. 177Yb has a half-life of only 1.9 h, 
purity is readily obtained. The issue however, is that the neutron cross section 
of is only 2.4 b, requiring a fairly long irradiation time (or higher neutron flux) to acquire much 
activity. 
To s u m m k  this section, radionuclides can be implanted in (& by recoil following neutron activation 
and derivatized via multiple malonic ester addition reactions to become soluble in a wide variety of 
organic solvents. However, the implantation occutred at rather low yields, a result due entirely to the 
preparation of the cold material. Unless the cold atoms to be activated are within a few nanometers of a 
lllerene cage, there is essentially no chance for them to be encapsulated via recoil. Physical mixing of 
oxides and Illerenes, despite a report in the literaave of high yields, allows only extremely poor 
encapsulation efficiencies (-0.001%)). Fortunately, the fundamental mixing problem is solvable, and 
probably solvable by a variety of methods, including co-precipitation of Ca and organometallics, 
formation of metal-Cm salts, and cdejmsition of and organometallic vapors on a substrate under 
vacuum. We have already observed a IO-fold increase in encapsulation efficiency by the most 
rudimentary of these techniques (co-precipitation), and believe that an efficiency of >1% would be 
rapidly attainable with continued effort. 
4.4. HPLC Separation of lnLu@C.a Bingel Ester from CoM Ca B i  Esters 
Although the malonic ester derivative of the 1nLu@c60 is now in hand, it is but a tiny portion of all the 
fullerene esters in solution. It must be purified b e h  it is suitable for conjugation to an antibody (Ab). 
Unlabeled mAbs or mAbs that are chelated with non-radioactive atoms are essentially “shooting blanks”. 
The final radiolllerene complex (before conjugation to the mAb) should contain at least 10% radioactive 
atoms to be competitive with cumnt didhenrpy techniques. However, this is only a guide; lower 
specific activity may be satisfactory depending on the specific therapy and &antage gained by using the 
Mlemne. Therefore, we needed to demonstrate that the radiofullerenes could be separated fhm the cold 
fitrction. 
We had originally considered exhaustive washing of the activated lllerene material prior to 
derivatization. Since Ln@cso (Ln = lanthanide) is insoluble in aromatic solvents such as xylene, while 
empty Ca is soluble, there appears to be the basis for a e o n .  Additional thought, however, 
suggests that the tiny percentage of Ln@Cm would more than likely be merely carried along in the 
solvent, perhaps in fullerem micelles. There are no regions of Ln@C60; no nanocrystals h m  which the 
surrounding material can be washed away. The Ln& is intermolecularly mixed with the empty Ca. 
The odds are strongly against the solvent selectively removing all Werenes round the endohedral one, 
while letting the cndohcdral fullertne settle to the bottom of the flask. 
Fortunately, the chemical differences between empty qnd lantknkbfilled f u l l e ~  manifest themselves 
in the number of malonic ester groups that add to the exterior of Werene cage. In the reaction conditions 
employed here, empty fillerenes add a mixture of 4 5 ,  or 6 malonic ester p u p s .  It is known that adding 
a lanthanide atom to Cm increases the number of malonic ester ligands to 10 when subjected to the same 
conditions (Bolskar et al., 2003). The varying number of malonic esters on the fullerene shell provides a 
means to chromatographically separate the endohedral fullerene esters h m  the empty fillerene esters. 
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Our approach to this problem was to search for a chromatographic method suitable for the separation of 
the 4,5, and 6 esters, reasoning that such a method would also be sufliciently powerhl to separate the 10 
ester endohedral Mlerene fiom the others. We initially predicted that a mobile phase of methanol with a 
little xylene in it over a reverse phase (C18) column would provide the necessary separation. While it 
provided Separation into two distinct peaks, which were collected as M o n s ,  the TOF-MS analysis of 
the M o n s  revealed that the esters had each lost 155 mass units. TOF-MS analysis of the ester 
dissolved in methanol (it is very slightly soluble) and filtered did not display such action, and neither the 
rationale for nor the identity of the fragment have been determined. In any case, a different method 
would be required. 
While using hexane to cut the toluene did not slow the esters h m  rushing straight over the C 18 colutnn, 
a one-to-one mixture provided both retention and Separation on our semi-prep Buclqclutcher column. 
Momver, TOF-MS of the collected fi.actions was able to identify each of the three peaks as 
corresponding to one of the esters. Their elution order was 4,5, and then 6. Using the photodiode array 
detector (PDA) at ORNL, the w-vis spectrum of each of the esters was observed as it eluted. The 
spectra, shown in Figure 22Figure, have distinctive features that allow us to identifi them without furuler 
TOF-MS analysis. That the features exist perhaps suggest that, as the C, becomes crowded, not so many 
isomem of a particular composition are possible. 
Figure 22: Lee: Absorbance at 310 nm of a mixture of empty Cm with 4, 5, and 6 malonic esters in 
toluene chromatographed on a semi-prep BuckyPrep column with 3 mL/min each toluene and hexane. 
Right: UV - vis absorbance at times corresponding to the vertical lines of the same color in the 
chromatogram, i.e. the double-humped dark blue spectrum elutes after the single-humped light blue, 
which is after the red with the absorbance in the visible. The two spectra with little absorbance are the 
last two vertical lines in the chromatogrm. 
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Predicting that the lo-ester Lu@Cm would elute far later than the empty fillerenes with 4,5, or 6 esters, 
we injected the mixture of hot and cold malonic ester derivatives using a flow of 3 mL/min each toluene 
and hexane over the BuckyPrep column. We collected fractions every 30 seumds Starting fiom injection, 
and counted the fractions individually on the Wallac Wizard. 
The results of the toluenehexam hot ester separation are given in Figure 23. In an effort to hcrease the 
counts, we saturated the detector in the uv with cold estery making it appear that we failed to achieve 
separation between the 4,5, and 6 esters. Nevertheless, spectra taken at various times within the large 
unresolved peak in Figure 23 show similar w-vis as those in Figure 22Figm. The plot of activity in 
each k t ion ,  however, is hard to completely understand The little bit of activity eluting prior to 2 
minutes is indicative of a small amount of the lnLu@Cm rushing through with the pure toluene it was 
injected in, the sodled "injection peak." This is to be expected. The lage amount of activity eluting 
between 2.5 and 3.5 min is very difficult to undemtand in the context of the empty Werene ester HPLC 
work, and the cold metallolllerene ester TOF-MS work. That some lnLu@c60 ester would elute with 
the empty Werene esters between 4 and 5.5 min is perhaps also reSlSOnable if the empty fullerene esters 
solvate, to some extent, the hot fullerene ester. Lastly, some activity seems to dribble off the column 
h m  six minutes on. Satisfyingly, over 40% of the injected activity eluted. We were concerned that 
active sites within the mlumn would cause the tiny amount of hot lllerene ester to retained on the 
column, since its diffkrmt chemistry precludes the empfy lllerenes fbm acting as true carriers. So it 
was very enmuraging that a large portion of the InLu was briefly retained on the column, and then eluted, 
more or less like the fullerene ester in which we expect it to be imvasibly encapsulated. Arguments that 
the lnLu is not really in the fullerene (if any muld be left after the washing exercise) are dispelled by this 
result. Howevery it also sppeared that a different chromatogmpbic method would be required to 
effectively separate and collect the "'LUGJC~. 
Since the BuekyRep stationary phase bas excellent selectivity for the fdleirm, we reasoned that the 
mobile phase should be direded towards the malonic ethyl esters. Thus, we selected ethylacetate for the 
mobile phase. An injection of cold esters into pure ethyl acetate produced a trio of @ally resolved 
peaks, as well as a leading peak that absorbs moderately in the w, and in invisible in the visible spectral 
region. The chromatogmm and the uv-vis of the major peaks in the chromatogram are shown in Figure 
24. Interesthgly, in corn- to the spectra obtained with t o l d =  (Figure 22), the elution order 
of the esters is reversed. With ethylacetate as the mobile phase, Mlercncs with six malonic esters, as 
identified by w-vis and TOF-MS, elute first. The lllerenes with five malonic esters are still in the 
middle, and those with 4 elute last. Thus, in ethylacetate, we expect the Lu metallolllerenes to be fmt 
off of the column. 
The merits of the ethylixdate+Buclcy~ chromatographic method were initially assessed with the ester formed h m  neutron activation of Lu(aCac) / & mixtures in DMF (Section 4.3.3). As can be seen in 
Figure 25, the activity eluted slightly before the empty lllerene peaks, exactly as expected. Obviously, 
some tailing under or co-solvation with the empty Merenes occc~ls, but further development of the this 
method can be expected to solve these problems. This Fesult was later repeated with 'nLu@c, esters. 
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Figure 23: Chromatogram of "Tu oxide + Ca mixture, derivatized by the Bingel p d u r e ,  loaded onto 
the BuckyPrep column, and eluted with 3 d m i n  toluene + 3 d m i n  hexane. Top: uv absorbance @ 
3 1 Onm. Bottom: InLu activity in hctions collected evety 30 seconds fiom injection. 
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Figure 24: Left: Absorbance at 310 nm of a mixture of empty Ca with 4, 5, and 6 malonic esters in 
toluene chromatographed on a semi-prep BuckyPrep column with 6 mL/mh ethylacetate. Right: UV - 
vis absorbance at times corresponding to the vertical lines of the same color in the chromatogram, i.e. the 
double-humped red spectrum elutes before the weak single-humped dark blue, which is before the light 
blue with the absorbance in the visible (470 nm). 
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A5 Summary of 'nLu@Ca Studies 
The primary achievement of this part of the project 
was that incontrovertible evidence for the production 
of 1 7 7 ~ u @ ~ a  via recoil implantation following 
neutron activation was obtained. We also established 
a rapid protocol for the chemical derivatization of the 
hot endohedral Illerene, leading to a robust, non- 
aggregating water-soluble radiofullerene derivative. 
Furthermore, we developed a chromatographic 
technique suitable for its fast, convenient purification 
from cold, derivatkd fullerenes. The 
chromatography will allow for arbitrarily high 
specific activity of '77~u-containing Illerenes to be 
obtained, limited only by the time between activation 
and separation. Although the (neutron capture) recoil 
implantation yield was not as high as originally 
expected, the reason for the discrepancy is 
understood, and solutions have been identified. In 
summary, we have demonstrated the promise of the 
recoil implantation technique for producing 
radiofbllerenes suitable for pharmaceutical 
development, met only readily surmountable hurdles, 
and remain enthusiastic about the continued 
development of the technique. 
Figwe 25: Chromatogram of Lu(acac) - CK, 
mixture, coprecipitated from DMF, activated, 
derivahd by the Binge1 procedure, loaded onto 
the BuckyPrep column, and eluted with 4 mL/min 
ethyl acetate+ 2 mL/min hexane. Top: uv 
absorbance @ 31Onm. Bottom: lnLu activity in 
fractions collected every 30 seconds from 
injection. 
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